These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


289 related items for PubMed ID: 2436796

  • 21. Regulation of the genes for interleukin-6 and granulocyte-macrophage colony stimulating factor by different inducers of differentiation in myeloid leukemic cells.
    Shabo Y, Lotem J, Sachs L.
    Leukemia; 1989 Dec; 3(12):859-65. PubMed ID: 2685477
    [Abstract] [Full Text] [Related]

  • 22. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA, Hoffman-Liebermann B.
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [Abstract] [Full Text] [Related]

  • 23. The control of hematopoiesis and leukemia: from basic biology to the clinic.
    Sachs L.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):4742-9. PubMed ID: 8643473
    [Abstract] [Full Text] [Related]

  • 24. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA, Hoffman B.
    Stem Cells; 1994 Jul 14; 12(4):352-69. PubMed ID: 7951003
    [Abstract] [Full Text] [Related]

  • 25. The proteins that control haemopoiesis and leukaemia.
    Sachs L.
    Ciba Found Symp; 1990 Jul 14; 148():5-19; discussion 19-24. PubMed ID: 2180649
    [Abstract] [Full Text] [Related]

  • 26. Co-regulation of type C RNA virus production and cell differentiation in myeloid leukemic cells.
    Liebermann D, Sachs L.
    Cell; 1978 Nov 14; 15(3):823-35. PubMed ID: 83197
    [Abstract] [Full Text] [Related]

  • 27. Epigenetics wins over genetics: induction of differentiation in tumor cells.
    Lotem J, Sachs L.
    Semin Cancer Biol; 2002 Oct 14; 12(5):339-46. PubMed ID: 12191633
    [Abstract] [Full Text] [Related]

  • 28. The Leo Sachs' legacy: a pioneer's journey through hematopoiesis.
    Lotem J, Groner Y.
    Int J Dev Biol; 2017 Oct 14; 61(3-4-5):127-136. PubMed ID: 28621410
    [Abstract] [Full Text] [Related]

  • 29. Cytokine control of developmental programs in normal hematopoiesis and leukemia.
    Lotem J, Sachs L.
    Oncogene; 2002 May 13; 21(21):3284-94. PubMed ID: 12032770
    [Abstract] [Full Text] [Related]

  • 30. Effects of recombinant human granulocyte colony stimulating factor (rG-CSF) on murine myeloid leukemia: stimulation of proliferation of leukemic cells in vitro and inhibition of development of leukemia in vivo.
    Tamura M, Hattori K, Ono M, Hata S, Hayata I, Asano S, Bessho M, Hirashima K.
    Leukemia; 1989 Dec 13; 3(12):853-8. PubMed ID: 2479801
    [Abstract] [Full Text] [Related]

  • 31. Target-cell specificity of hematopoietic regulatory proteins for different clones of myeloid leukemic cells: two regulators secreted by Krebs carcinoma cells.
    Shabo Y, Lotem J, Sachs L.
    Int J Cancer; 1988 Apr 15; 41(4):622-8. PubMed ID: 3258591
    [Abstract] [Full Text] [Related]

  • 32. The control of growth and differentiation in normal and leukemic blood cells.
    Sachs L.
    Cancer; 1990 May 15; 65(10):2196-206. PubMed ID: 2189550
    [Abstract] [Full Text] [Related]

  • 33. TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.
    Plasilova M, Zivny J, Jelinek J, Neuwirtova R, Cermak J, Necas E, Andera L, Stopka T.
    Leukemia; 2002 Jan 15; 16(1):67-73. PubMed ID: 11840265
    [Abstract] [Full Text] [Related]

  • 34. Hemopoietic colonies: in vitro cloning of normal and leukemic cells.
    Metcalf D.
    Recent Results Cancer Res; 1977 Jan 15; (61):Title page, 1-227. PubMed ID: 143701
    [No Abstract] [Full Text] [Related]

  • 35. Regulation and role of different macrophage-and granulocyte-inducing proteins in normal and leukemic myeloid cells.
    Liebermann D, Hoffman-Liebermann B, Sachs L.
    Int J Cancer; 1982 Feb 15; 29(2):159-61. PubMed ID: 6977501
    [Abstract] [Full Text] [Related]

  • 36. Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells.
    Azumi JI, Sachs L.
    Proc Natl Acad Sci U S A; 1977 Jan 15; 74(1):253-7. PubMed ID: 264678
    [Abstract] [Full Text] [Related]

  • 37. Control of in vivo differentiation of myeloid leukemic cells. IV. Inhibition of leukemia development by myeloid differentiation-inducing protein.
    Lotem J, Sachs L.
    Int J Cancer; 1984 Jan 15; 33(1):147-54. PubMed ID: 6582051
    [Abstract] [Full Text] [Related]

  • 38. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
    Kawagoe H, Potter M, Ellis J, Grosveld GC.
    Cancer Res; 2004 Sep 01; 64(17):6091-100. PubMed ID: 15342392
    [Abstract] [Full Text] [Related]

  • 39. Granulocyte colony-stimulating factor and differentiation-induction in myeloid leukemic cells.
    Nicola NA.
    Int J Cell Cloning; 1987 Jan 01; 5(1):1-15. PubMed ID: 3031177
    [Abstract] [Full Text] [Related]

  • 40. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH, Talpaz M, Deisseroth AB, Estrov Z.
    Leukemia; 1996 May 01; 10(5):757-65. PubMed ID: 8656668
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.